Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2018 14:07 ET | Source: resTORbio, Inc.

resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older

resTORbio’s TORC1 inhibitors enhanced the function of the aging immune system and were associated with a statistically significant decrease in the incidence of all infections, including respiratory...
June 12, 2018 08:00 ET | Source: resTORbio, Inc.

resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development

BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC) today announced that Kerry Russell, M.D., Ph.D., has joined the company as its Vice President of Clinical Development, a newly...
June 01, 2018 08:00 ET | Source: resTORbio, Inc.

resTORbio to Present at the Jefferies 2018 Global Healthcare Conference

BOSTON, June 01, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
May 22, 2018 16:30 ET | Source: resTORbio, Inc.

resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition

BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
May 10, 2018 16:01 ET | Source: resTORbio, Inc.

resTORbio Reports First Quarter 2018 Financial Results

Last patient dosed in Phase 2b trial; topline data now expected in third quarter of 2018 BOSTON, May 10, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical...
May 09, 2018 16:05 ET | Source: resTORbio, Inc.

resTORbio to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
May 09, 2018 08:30 ET | Source: resTORbio, Inc.

resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly

BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
May 01, 2018 16:05 ET | Source: resTORbio, Inc.

resTORbio to Present at the Deutsche Bank 43rd Annual Health Care Conference

BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
March 29, 2018 16:05 ET | Source: resTORbio, Inc.

resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results

BOSTON, March 29, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
March 19, 2018 08:00 ET | Source: resTORbio, Inc.

resTORbio Announces Formation of Clinical Advisory Board

Esteemed Experts Engaged as Company Advances Clinical Development Program Phase 2b Data for Lead Program Expected in the Second Half of 2018 BOSTON, March 19, 2018 (GLOBE NEWSWIRE) -- resTORbio,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right